Intravascular (IV) administration of contrast media (CM) is commonly utilized to enhance the capabilities of imaging modalities commonplace in both diagnostic and therapeutic interventions. There are numerous iatrogenic reactions associated with CM administration that have been described in literature,[1] broadly categorized as allergic and nonallergic. Postcontrast acute kidney injury (PC-AKI) is a subset of nonallergic CM reactions and is especially important in patients with an underlying medical condition such as chronic kidney disease (CKD). This may be exacerbated by IV administration of CM during long interventional procedures such as angiography. In this article, a case of PC-AKI is presented followed by a discussion of the topic. In addition, guidelines for prevention and treatment of PC-AKI are presented.
2
Stacul F,
van der Molen AJ,
Reimer P.
et al;
Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR).
Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011; 21 (12) 2527-2541
5
van der Molen AJ,
Reimer P,
Dekkers IA.
et al.
Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors: recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 2018; 28 (07) 2845-2855
6
Davenport MS,
Perazella MA,
Yee J.
et al.
Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Radiology 2020; 294 (03) 660-668
8
Andreucci M,
Faga T,
Pisani A,
Sabbatini M,
Michael A.
Acute kidney injury by radiographic contrast media: pathogenesis and prevention. BioMed Res Int 2014; 2014: 362725
9
Detrenis S,
Meschi M,
Musini S,
Savazzi G.
Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art. Nephrol Dial Transplant 2005; 20 (08) 1542-1550
10
Andreucci M,
Solomon R,
Tasanarong A.
Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. BioMed Res Int 2014; 2014: 741018
13
Ulas T,
Buyukhatipoglu H,
Dal MS.
et al.
Urotensin-II and endothelin-I levels after contrast media administration in patients undergoing percutaneous coronary interventions. J Res Med Sci 2013; 18 (03) 205-209
14
Heyman SN,
Rosenberger C,
Rosen S,
Khamaisi M.
Why is diabetes mellitus a risk factor for contrast-induced nephropathy?. BioMed Res Int 2013; 2013: 123589
21
Bucher AM,
De Cecco CN,
Schoepf UJ.
et al.
Is contrast medium osmolality a causal factor for contrast-induced nephropathy?. BioMed Res Int 2014; 2014: 931413
22
Pflueger A,
Larson TS,
Nath KA,
King BF,
Gross JM,
Knox FG.
Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus. Mayo Clin Proc 2000; 75 (12) 1275-1283
26
Zoungas S,
Ninomiya T,
Huxley R.
et al.
Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med 2009; 151 (09) 631-638
27
Hiremath S,
Akbari A,
Shabana W,
Fergusson DA,
Knoll GA.
Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence. PLoS One 2013; 8 (03) e60009
28
Søreide E,
Ljungqvist O.
Modern preoperative fasting guidelines: a summary of the present recommendations and remaining questions. Best Pract Res Clin Anaesthesiol 2006; 20 (03) 483-491
29
Subramaniam RM,
Suarez-Cuervo C,
Wilson RF.
et al.
Effectiveness of prevention strategies for contrast-induced nephropathy: a systematic review and meta-analysis. Ann Intern Med 2016; 164 (06) 406-416
30
Pappy R,
Stavrakis S,
Hennebry TA,
Abu-Fadel MS.
Effect of statin therapy on contrast-induced nephropathy after coronary angiography: a meta-analysis. Int J Cardiol 2011; 151 (03) 348-353
31
Li Y,
Liu Y,
Fu L,
Mei C,
Dai B.
Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials. PLoS One 2012; 7 (04) e34450
